marijuana stocks

Canopy Growth and Hiku Announce Closing of Acquisition

Canopy Growth Corporation (“Canopy Growth”) (WEED.TO) (CGC) and Hiku Brands Company Ltd. (“Hiku”) (HIKU.CN) (together, the “Companies”) are pleased to announce the closing of the previously announced acquisition of Hiku by Canopy Growth (the “Transaction”).

Today’s announcement follows Hiku’s special meeting of shareholders held on August 30, 2018 where holders of the common shares of Hiku (the “Hiku Shares”) voted to approve the Transaction.

“Leaves begin to turn. Canopy adds bold new brands. Ready for retail,” commented Bruce Linton , Chairman & Co-CEO, Canopy Growth. “The Tweed and Vert brands we’ve built are now complemented with the likes of DOJA, Tokyo Smoke, Maitri, and Van der Pop , placing the taste-makers of tomorrow’s cannabis industry on the same team.”

“Since day one we’ve believed in a singular vision – that recreational cannabis is a consumer product and that consumers will ultimately choose brands they identify with from exceptional retail environments,” said Alan Gertner , CEO, Hiku. “Today is a pivotal moment in our journey as it represents the chance to tell our story on the biggest stage with the greatest cannabis company the world has ever seen. We could not be more honoured to bring best in class brands and retail to consumers alongside Canopy Growth.”

As a result of the Transaction, Hiku has become a wholly-owned subsidiary of Canopy Growth and the Hiku Shares are anticipated to be de-listed from the Canadian Securities Exchange on September 6, 2018 . Trading of the Hiku Shares was halted on the Canadian Securities Exchange as of noon on August 31, 2018 . Pursuant to the Transaction, Canopy Growth acquired 100% of the issued and outstanding common shares of Hiku and Hiku shareholders are entitled to receive 0.046 of a Canopy Growth common share in exchange for each Hiku Share held immediately prior to the closing.

Full details of the Transaction are set out in the management information circular of Hiku dated July 27, 2018 (the “Information Circular”). A copy of the Information Circular and the early warning report to be filed by Canopy Growth in connection with the purchase of the Hiku Shares can be found under Hiku’s profile on SEDAR at www.sedar.com or by contacting Canopy Growth as set out below.

Here’s to Future Growth (and welcoming Hiku to the Canopy family!).

About Canopy Growth Corporation
Canopy Growth is a world-leading diversified cannabis and hemp company, offering distinct brands and curated cannabis varieties in dried, oil and Softgel capsule forms. From product and process innovation to market execution, Canopy Growth is driven by a passion for leadership and a commitment to building a world-class cannabis company one product, site and country at a time.

The Company has operations in 11 countries across five continents. The Company is proudly dedicated to educating healthcare practitioners, conducting robust clinical research, and furthering the public’s understanding of cannabis, and through its partly owned subsidiary, Canopy Health Innovations, has devoted millions of dollars toward cutting edge, commercializable research and IP development. Through partly owned subsidiary Canopy Rivers Corporation, the Company is providing resources and investment to new market entrants and building a portfolio of stable investments in the sector. From our historic public listing on the Toronto Stock Exchange and New York Stock Exchange to our continued international expansion, pride in advancing shareholder value through leadership is engrained in all we do at Canopy Growth.


MAPH Enterprises, LLC | (305) 414-0128 | 1501 Venera Ave, Coral Gables, FL 33146 | new@marijuanastocks.com
Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

Organigram Holdings Inc. (OGI) Announces Pricing of Overnight Marketed Public Offering

Organigram Announces Pricing of Overnight Marketed Public Offering Organigram Holdings Inc. (“Organigram”…

GWPH Notes New Epidiolex(R) Data Released by the American Academy of Neurology

GW Pharmaceuticals Notes New Epidiolex(R) Data Released by the American Academy of…

$PNTV Files Second Amended Complaint Against Comcast Corporation

Player’s Network Inc. Files Second Amended Complaint Against Comcast Corporation and Resumes…